Search Results - "Epner EM"

A phase I study using bortezomib (Velcade), cladribine, and rituximab in treating patients over 50 years old with mantle cell lymphoma.

Authors: Pu JJ Berger KN Zheng C et al.

Source: Frontiers in oncology [Front Oncol] 2024 Dec 16; Vol. 14, pp. 1449401. Date of Electronic Publication: 2024 Dec 16 (Print Publication: 2024).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Development of an Optimized CXCR4-Targeting Theranostic Pair.

Authors: Kwon, Daniel Bloise, Ingrid Zhang, Zhengxing et al.

Source: Journal of Nuclear Medicine. May2026, Vol. 67 Issue 5, p773-779. 7p.

Long-Term Therapeutic Outcomes with Cladribine in Patients with Xanthoma Disseminatum.

Authors: Sharma, Ananya Taneja, Neha Sharma, Ritu et al.

Source: Indian Dermatology Online Journal. Sep/Oct2025, Vol. 16 Issue 5, p765-772. 8p.

Mantle cell lymphoma management trends and novel agents: where are we going?

Authors: Pu JJ Savani M Huang N et al.

Source: Therapeutic advances in hematology [Ther Adv Hematol] 2022 Feb 26; Vol. 13, pp. 20406207221080743. Date of Electronic Publication: 2022 Feb 26 (Print Publication: 2022).

Publication Type: Journal Article

Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101549589 Publication Model: eCollection Cited Medium: Print ISSN: 2040-6207 (Print) Linking ISSN: 20406207 NLM ISO Abbreviation: Ther Adv Hematol Subsets: PubMed not MEDLINE

A multicenter phase II study of bendamustine, rituximab, and cytarabine (BRAC) for relapsed or refractory patients with follicular lymphoma or mantle cell lymphoma.

Authors: Nakamura, Nobuhiko Kasahara, Senji Kitagawa, Junichi et al.

Source: Experimental Hematology & Oncology. 2/25/2022, Vol. 11 Issue 1, p1-4. 4p.

Long‐term outcome in patients with mantle cell lymphoma following high‐dose therapy and autologous stem cell transplantation.

Authors: Metzner, Bernd Müller, Thomas H. Casper, Jochen et al.

Source: European Journal of Haematology. Aug2023, Vol. 111 Issue 2, p220-228. 9p.

IDH2 mutations in patients with normal karyotype AML predict favorable responses to daunorubicin, cytarabine and cladribine regimen.

Authors: Libura, Marta Bialopiotrowicz, Emilia Giebel, Sebastian et al.

Source: Scientific Reports. 5/11/2021, Vol. 11 Issue 1, p1-13. 13p.

Comparative preclinical drug response analyses of T-prolymphocytic leukemia reveal no differences between known gene expression subgroups.

Authors: Mikhaylenko, Nathan Braun, Till Timonen, Sanna et al.

Source: Biology Direct. 10/27/2025, Vol. 20 Issue 1, p1-18. 18p.

Decitabine as epigenetic priming with CLAG induce improved outcome of relapsed or refractory acute myeloid leukemia in children.

Authors: Zhang, Na Li, Hong Wang, Dan et al.

Source: Clinical Epigenetics. 5/9/2024, Vol. 16 Issue 1, p1-11. 11p.

Clemastine alleviates cognitive dysfunction after SAH by targeting neuronal CNTN1 to regulate the ADA-adenosine pathway.

Authors: Li LX Wei BY Jin L et al.

Source: Acta pharmacologica Sinica [Acta Pharmacol Sin] 2026 Jun 23. Date of Electronic Publication: 2026 Jun 23.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 100956087 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1745-7254 (Electronic) Linking ISSN: 16714083 NLM ISO Abbreviation: Acta Pharmacol Sin Subsets: MEDLINE

METTL3 regulates Ambra1 expression in an m6A-YTHDF2-dependent manner to promote mantle cell lymphoma progression.

Authors: Li, Shujun Jiang, Zhiping Wei, Wenjia et al.

Source: Journal of Translational Medicine. 7/1/2025, Vol. 23 Issue 1, p1-18. 18p.

Unraveling the complexity of the histone code: implications for gene regulation and disease.

Authors: Malone KL Singh AK Lignos JM et al.

Source: Genome biology [Genome Biol] 2026 Mar 24; Vol. 27 (1). Date of Electronic Publication: 2026 Mar 24.

Publication Type: Journal Article; Review

Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100960660 Publication Model: Electronic Cited Medium: Internet ISSN: 1474-760X (Electronic) Linking ISSN: 14747596 NLM ISO Abbreviation: Genome Biol Subsets: MEDLINE

Mantle cell lymphoma negative for t(11,14) involving the kidneys: a case report.

Authors: Nassereldine, Hasan Mohty, Razan Awada, Hussein et al.

Source: Journal of Medical Case Reports. 6/29/2022, Vol. 16 Issue 1, p1-5. 5p.

Sox6 directly silences epsilon globin expression in definitive erythropoiesis.

Authors: Yi Z Cohen-Barak O Hagiwara N et al.

Source: PLoS genetics [PLoS Genet] 2006 Feb; Vol. 2 (2), pp. e14. Date of Electronic Publication: 2006 Feb 03.

Publication Type: Journal Article

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101239074 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1553-7404 (Electronic) Linking ISSN: 15537390 NLM ISO Abbreviation: PLoS Genet Subsets: MEDLINE

Combination of rituximab with chlorambucil as first line treatment in patients with mantle cell lymphoma: a highly effective regimen.

Authors: Sachanas, Sotirios Pangalis, Gerassimos A. Vassilakopoulos, Theodoros P. et al.

Source: Leukemia & Lymphoma. Mar2011, Vol. 52 Issue 3, p387-393. 7p. 1 Black and White Photograph, 1 Chart, 2 Graphs.

Targeting CD83 in mantle cell lymphoma with anti‐human CD83 antibody.

Authors: Li, Ziduo Abadir, Edward Lee, Kenneth et al.

Source: Clinical & Translational Immunology. 2020, Vol. 9 Issue 7, p1-12. 12p.

Intensive therapies for mantle cell lymphoma: time for a disease-specific approach?

Authors: Smith, Stephen D. Sweetenham, John W.

Source: Leukemia & Lymphoma. Mar2010, Vol. 51 Issue 3, p357-359. 3p.

Maintenance rituximab following induction chemo-immunotherapy for mantle cell lymphoma: long-term follow-up of a pilot study from the Wisconsin Oncology Network.

Authors: Kenkre, Vaishalee P. Long, Walter L. Eickhoff, Jens C. et al.

Source: Leukemia & Lymphoma. Sep2011, Vol. 52 Issue 9, p1675-1680. 6p. 4 Graphs.

Cyclin D1 positive diffuse large B-cell lymphoma is a post-germinal center-type lymphoma without alterations in the CCND1 gene locus.

Authors: Vela-ChÁvez, Teresa Adam, Patrick Kremer, Marcus et al.

Source: Leukemia & Lymphoma. Mar2011, Vol. 52 Issue 3, p458-466. 9p. 1 Color Photograph, 1 Chart, 1 Graph.

Bilan d’activité de l’unité de greffe de moelle osseuse du Centre Hospitalier Universitaire Mohamed VI de Marrakech, Maroc: 2012-2018.

Alternate Title: Activity report of the Bone Marrow Transplant Department of the Mohammed VI University Hospital, Marrakech, Morocco, over the period 2012- 2018.

Authors: Loukhnati, Mehdi Lahlimi, Fatima Ezzahra Tazi, Illias

Source: Pan African Medical Journal. May-Aug2021, Vol. 39, p1-13. 13p.